title: Intravenous magnesium sulphate prevents intravenous salbutamol tachycardia in asthma.
authors.forename: W F S
authors.initials: WF
authors.lastname: Sellers
authors.forename: I
authors.initials: I
authors.lastname: Ahmad
authors.forename: P S J
authors.initials: PS
authors.lastname: Bathke
authors.forename: C J
authors.initials: CJ
authors.lastname: Brown
authors.forename: T
authors.initials: T
authors.lastname: Fernandez
authors.forename: A
authors.initials: A
authors.lastname: Barker
mesh_terms: D000293:Adolescent; D058666:Adrenergic beta-2 Receptor Agonists / Q000627:therapeutic use; D000420:Albuterol / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000009:adverse effects; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008278:Magnesium Sulfate / Q000627:therapeutic use*; D008875:Middle Aged; D013610:Tachycardia / Q000517:prevention & control*
chemical_list: D058666:Adrenergic beta-2 Receptor Agonists; D000889:Anti-Arrhythmia Agents; D001993:Bronchodilator Agents; D008278:Magnesium Sulfate; D000420:Albuterol